Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Imquest seems pretty squared away.
http://imquestbio.com/
And with 2 pre-IND meetings coming up MBRX just may gain some traction.
I don't think so. They don't know the right people...if they knew the right people, they would not have been halted in the first place. They're crossing their Ts and dotting their Is because they cannot afford to get shut down again. They simply don't know the right people.
This could get interesting!!
Although developing in vitro data is an initial step and the data may not necessarily reflect the antiviral effects in vivo, the results of this repeated round of in vitro testing received on June 1, 2020, confirm that WP1122 has an antiviral effect on Human Coronavirus 229E ("HCoV-229E"), a surrogate of SARS-CoV-2, the virus responsible for COVID-19.
"We felt it was important to confirm these results," commented Walter Klemp, Chairman and CEO of Moleculin, "so, out of an abundance of caution, we had an independent testing contractor run them a second time. While the results are encouraging, we believe, based on guidance from the FDA, we will need additional studies to further assess WP1122's antiviral capability, and consistent with our previous guidance, we will continue to push forward with additional in vitro and in vivo testing with the goal of a possible IND filing by the end of 2020, in preparation for beginning a human clinical trial thereafter."
https://finance.yahoo.com/news/moleculin-announces-confirmatory-vitro-analysis-113000953.html
Nice. Traded as high as 1.22 today and is up in AH trading.
Trading at 1.14 after trading as high of 1.16.
HEHHEHE DENNIS
Where is everyone??????????????? lmaorotf
I always say ""IT TAKE 2 to 3 days for the market to digest news!
Lets see what Monday brings us possibly an 8K
Getting close to .99. The clock starts.
KING
""" All we know for sure is that they want to do a reverse split and issue massive dilution."""
Where may I ask have you seen THEY WANT TO DO A REVERSE SPLIT.
All we HAVE seen is they're wanting to have shares available IN CASE they need to do a RS.
JUST Keeping it real
Apples to ELEPHANTS
The more press releases they issue the more the stock goes down. It’s so predictable it’s like free money.
This is the only company that has news comes out and it drops like beans in milk. Very easy to make money.giggles
Given the recent revelations how can anyone know what news is true vs fake? All we know for sure is that they want to do a reverse split and issue massive dilution.
Definitely! They're very active, which is good.
Sounds like this is moving to higher and higher grounds the way these updates keep coming. I expect an 8K filing within days to two weeks and probably on Monday morning discussing much more.
Taking advantage of anyone even on a MESSAGE BOARD, HEARTLESS!!!!!!!
HUSH ON GAPS!!!!!!!!! I HATE GAPS!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
It all reminds me of the movie boiler room.
They take advantage of a 97 yo. That’s heartless.
Good luck with that lol
More likely to gap to $2
Looks like it needs to retrace back to .56 . i was told all gaps get filled 95% of the time. The big gap up was from the fake news 2 months ago
He understands 100% that those that bought accumulated!!!!!!!!!!
Looks like the stock has lost all support. Time running out before it goes below $1 again.
I accumulated more today ! :))))$
OH REALLY NOW !!!!!!!!!!!!!!!!!!!
600K were accumulated by THOSE THAT BOUGHT THEM!!!!!!!!!!!!!!!!
Ya can't buy more or ACCUMULATE MORE than are put up for sale
But WHOMEVER BOUGHT EM ACCUMULATED THEM
600k bought, 600k sold. No accumulation
Solid day of accumulating,, this is gonna run hard next week
WHEN?????????????????
DON'T YOU MEAN IF IF IF that happens
Not good for longs. When the r/s happens, its a 40% haircut easy.
In May 2016 and April 2017, Moleculin disclosed in its S-1 and Form 10-K that its rights to WP1122 could be terminated by MD Anderson if certain development milestones were not met within prescribed periods of time. Thereafter, the company removed the disclosure from its financial statements and has since made no reference to the possibility of the termination of the license rights.
The staff obtained from MD Anderson a more recent amendment to the license agreement between Moleculin and MD Anderson, which was signed in November 2018. This amendment modifies MD Anderson’s termination rights. Although Moleculin has disclosed the underlying license agreement with MD Anderson as an exhibit to its annual 10-K filings with the Commission, it has not disclosed the November 2018 amendment. That amendment affords MD Anderson the right to terminate the license if Moleculin does not file an IND with the FDA for a Phase I clinical trial by May 1, 2020
FOR HOW MANY DAYS does it have to CLOSE below 1$ hehehehe before that happens
That SHOULD have already happened if IF IF it was gonna take place, BUT YOU KNOW THAT
if it can't hold above $1 it will be out of compliance again with NASDAQ. This makes the reverse split even more likely.
This stock is a shorts wet dream.
This is easy pickens. 7 % haircut every day. Buzzzzzzzzzzz
this is just sick
FINRA’s preliminary analysis of bluesheeting for WPD during the period from March 25 through March 30 identified 23 accounts tied to individuals 55 years or older that collectively purchased 77,733 WPD shares, representing approximately 95% of the retail buying volume. The staff spoke to two of these traders, aged 97 and 91, both of whom recalled receiving cold calls to purchase WPD stock in the late January timeframe, another period of abnormally high daily volume.
On April 20, Moleculin announced an agreement with contract research organization ImQuest Biosciences to expand coronavirus testing. The staff spoke to ImQuest and learned that they will not be testing WP1122 on COVID-19, but rather will be testing on other coronavirus surrogates. Moleculin’s release states “we are determined to generate critical data over the next 4 to 8 weeks that will support an IND.” ImQuest explained to the staff that their research is limited to only one component of the necessary data.
This is serious
On March 17, 2020, Moleculin entered into an agreement to provide WP1122 to a researcher at the University of Texas Medical Branch (“UTMB”) to study the effects of the active ingredient in WP1122 on the infectivity of viruses. In an article in the Houston Chronicle on March 19, 2020, Moleculin’s CEO Walter Klemp linked WP1122’s purported ability to “slow
down the replication of a virus or maybe even stop the replication of the virus” to the potential to treat COVID-19. The article reported that it would be some time before WP1122 would be available to the public but that “Klemp is encouraged by the possibility of preventing future
outbreaks.”
The staff spoke to the UTMB professor who will be studying WP1122. Most significantly, he noted he was unaware of any research that had yet been conducted to evaluate WP1122’s impact on viruses. He also noted that he had not yet started any work to evaluate WP1122 himself and that he is not working at the direction of any of the companies to complete
any specified research.
WPD issued its own press release about Moleculin’s agreement with UTMB on March 19, 2020. That same day, Bullvestor, an Austrian stock promoter, published an article on its website describing WPD’s drug candidate as a “Corona Remedy Sponsored by the US Department of Defense.” No evidence existed that WP1122 would prove to be a COVID-19
remedy or that the drug candidate had received any sponsorship. The author of the Bullvestor article claimed to be a consultant of WPD who was compensated to draft it on the company’s behalf.
It's not on it's way down. You can't watch this second to second, or minute to minute, or day to day. The stock is trading when it was 10 days ago and 20 days ago, and in between it has traded higher. News is coming and when it does the stock will skyrocket.
Looks like it. If even half those allegations are true this won’t end well for shareholders.
It’s on the way down. Shorts are having the last laugh. All of those allegations must be under investigation and will destroy this company.
Not on the GREYS not tanked by 50% or more, NO HUGE volumes on the sell side,
THINGS THAT MAKE YA GO HMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMMM
Sinking faster than a bag of beans in soy milk
YOU NEED TO HAVE the FIRST BLOOD bath to have another one don't you????????
YOUSOFUNNY "BLOOD BATH"" lol BLOOD baths are in the 25%-50% range not 2-3%, also where is the HUGE VOLUME that comes with a major bloodbath
DENNIS
THIS thing has held UP VERY WELL with what it has been through.
Down 2 cents yesterday was a bloodbath LMAO!!!!!!!!!!!!!!!!!!!!!
Followers
|
90
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3504
|
Created
|
06/17/16
|
Type
|
Free
|
Moderators |
WALTER V. KLEMP
President, CEO and Chairman
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |